Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8304097 | Biochimie | 2018 | 7 Pages |
Abstract
Metformin enhanced SOD and GPx activities in type 2 diabetes patients but the reflection of this increase to the total antioxidant capacity was not significant. Although the increase in DNA pol beta was not significant, XRCC1 and p53 levels were significantly upregulated with metformin treatment in type 2 diabetes patients. Our study reinforces the potential benefit of metformin in antioxidative capacity to protect cells from diabetic oxidative stress and in regulation of DNA BER system.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Irem Dogan Turacli, Tuba Candar, Emine Berrin Yuksel, Sebnem Kalay, Ali Kemal Oguz, Selda Demirtas,